Dr Jack Otto Glander, DDS in Bellcourt, ND - Dentist

Dr Jack Otto Glander, DDS is a Dentist based in Bellcourt, North Dakota. Dr Jack Otto Glander is licensed to practice in North Dakota (license number 1384) and his current practice location is 1 Hospital Rd, Bellcourt, North Dakota. He can be reached at his office (for appointments etc.) via phone at (701) 477-6111.

NPI number for Dr Jack Otto Glander is 1962579011 and his current mailing address is Rr 1 Box 87p, Rolette, North Dakota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1962579011.

Contact Information

	Dr Jack Otto Glander, DDS
	1 Hospital Rd, Bellcourt, ND 58316
	(701) 477-6111
	Not Available

Healthcare Provider's Profile

Full Name	Dr Jack Otto Glander
Gender	Male
Speciality	Dentist
Location	1 Hospital Rd, Bellcourt, North Dakota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1962579011
Provider Enumeration Date: 11/30/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Jack Otto Glander such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1962579011	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
122300000X	Dentist	1384 (North Dakota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jack Otto Glander is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Jack Otto Glander, DDS Rr 1 Box 87p, Rolette, ND 58366-9764 Ph: (701) 246-3696	Dr Jack Otto Glander, DDS 1 Hospital Rd, Bellcourt, ND 58316 Ph: (701) 477-6111

News Archive

Hot spots where covid vaccination lags push experimental antibody treatment

For months, Joelle Ruppert was among the millions of Americans who are covid vaccine holdouts. Her reluctance, she said, was not so much that she opposed the new vaccines but that she never felt "compelled" by the evidence supporting their experimental use.

Iowa, Kentucky get extra time to comply with MLR rule

But North Dakota became the first state to have the Department of Health and Human Services deny a waiver request regarding the health law's medical loss ratio provision, which requires health plans in the individual and small-group markets to spend no more than 20 percent of premiums on administrative costs.

Pro Lab Marketing receives distribution rights for Vivakor's VivaThermic cryovials in India

Vivakor, Inc. announces distribution of its VivaThermic products to the rapidly growing biotech/biopharma industries in India through its agreement with Pro Lab Marketing Pvt. Ltd.

Interactions between carbon nanotubes and individual chemical functional groups

Carbon nanotubes have been employed for a variety of uses including composite materials, biosensors, nano-electronic circuits and membranes.

Dr Jack Otto Glander, DDS - Dentist in Bellcourt, ND